Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
918 trades
$10.3T in total
Open-market sales
1,145 trades
$2B in total
Insiders filing
485 insiders
Last 7 days
GeneDx HoldingsWGS
5,410 sh$458,50009/01Filed 09/01
Stueland KatherineOfficer, Director
GeneDx HoldingsWGS
14,243 sh$1,208,10009/09Filed 09/01
GeneDx HoldingsWGS
5,804 sh$366,00004/29Filed 04/29
Stueland KatherineDirector, Officer
GeneDx HoldingsWGS
16,415 sh$1,037,50004/29Filed 04/29
GeneDx HoldingsWGS10b5-1 plan
9,374 sh$929,90002/02Filed 02/02
GeneDx HoldingsWGS
24,155 sh$2,369,70001/29Filed 01/29
Stueland KatherineOfficer, Director
GeneDx HoldingsWGS
94,495 sh$9,268,70001/29Filed 01/29
GeneDx HoldingsWGS
38,000 sh$6,093,96925/11/24Filed 25/11/24
GeneDx HoldingsWGS10b5-1 plan
5,805 sh$625,40025/09/30Filed 25/09/30
GeneDx HoldingsWGS10b5-1 plan
6,609 sh$716,26025/09/30Filed 25/09/30
Stueland KatherineOfficer, Director
GeneDx HoldingsWGS10b5-1 plan
16,425 sh$1,769,60025/09/30Filed 25/09/30
Stueland KatherineOfficer, Director
GeneDx HoldingsWGS10b5-1 plan
12,858 sh$1,390,91225/09/30Filed 25/09/30
Jason RyanDirector
GeneDx HoldingsWGS
39,222 sh$4,990,00025/08/27Filed 25/08/27
GeneDx HoldingsWGS
500,000 sh$60,451,95025/08/22Filed 25/08/22
GeneDx HoldingsWGS10b5-1 plan
5,805 sh$535,90025/07/01Filed 25/07/01
GeneDx HoldingsWGS10b5-1 plan
6,622 sh$613,30025/07/01Filed 25/07/01
Stueland KatherineDirector, Officer
GeneDx HoldingsWGS10b5-1 plan
16,425 sh$1,516,20025/07/01Filed 25/07/01
Stueland KatherineDirector, Officer
GeneDx HoldingsWGS10b5-1 plan
12,877 sh$1,177,60025/07/01Filed 25/07/01
GeneDx HoldingsWGS
5,009 sh$363,40025/06/09Filed 25/06/09
Stueland KatherineOfficer, Director
GeneDx HoldingsWGS
14,139 sh$1,025,80025/06/09Filed 25/06/09